<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Severe <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001875'>neutropenia</z:hpo> <z:chebi fb="0" ids="29425">(SCN)</z:chebi> is characterized by a profound <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, which mostly presents during the neonatal period </plain></SENT>
<SENT sid="1" pm="."><plain>The precise genetic basis of <z:chebi fb="0" ids="18022">SCN</z:chebi> remains elusive </plain></SENT>
<SENT sid="2" pm="."><plain>Acquired <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> involving the carboxy-terminus of the G-CSF receptor (G-CSFR) have been found, often in association with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The authors describe a girl with <z:chebi fb="0" ids="18022">SCN</z:chebi> who did not respond to pharmacologic doses of filgrastim </plain></SENT>
<SENT sid="4" pm="."><plain>Genetic analysis of bone marrow and germline cells revealed a 182-bp deletion in the extracellular domain of the G-CSFR </plain></SENT>
<SENT sid="5" pm="."><plain>Co-precipitation studies showed an association between the <z:mp ids='MP_0002169'>wild-type</z:mp> and mutant G-CSFR, confirmed by their co-localization by confocal microscopy </plain></SENT>
<SENT sid="6" pm="."><plain>Coexpression of the mutant receptor inhibited the <z:mp ids='MP_0002169'>wild-type</z:mp> response in Ba/F3 cells </plain></SENT>
<SENT sid="7" pm="."><plain>These findings establish a novel constitutional defect in the G-CSFR that supports a partial dominant negative mechanism for receptor dysfunction in <z:chebi fb="0" ids="18022">SCN </z:chebi></plain></SENT>
</text></document>